NEWS

NEWS TYPE
RELEASE YEAR

RESEARCH

[Publication] Neuromodulation by the immune system: implications for brain-directed immunotherapy

July 28, 2025

Co-authored by a Bio2Q researcher, this Review explores how the brain-immune axis acts as a key regulator of brain function and behavior through direct interactions with neural circuits. This work highlights how immunotherapies targeting neuroimmune pathways may offer therapeutic potential for psychiatric and neurological conditions.

Title Neuromodulation by the immune system: implications for brain-directed immunotherapy
Authors Daniel H Cho [1],[2], Jun R Huh [3], [4],[5], Gloria B Choi [1],[2]
Short Description This Review article, co-authored by a Bio2Q researcher, explores the growing recognition of the brain-immune axis as an important modulator of brain function and behavior, challenging the traditional view of the brain as immunologically isolated. This piece highlights how immune molecules, including cytokines and chemokines, influence neural activity, learning, memory, social behavior, and stress responses. The authors discuss the therapeutic potential of immunomodulatory approaches for neurological and psychiatric conditions, drawing on evidence from both animal models and clinical studies. This Review emphasizes recent findings that show immune signaling is a compelling target for brain-directed immunotherapy, and will provide a valuable resource that can be used to guide future research in neuroimmunology.
DOI https://doi.org/10.1016/j.coi.2025.102568.
Journal Current Opinion in Immunology
Vol/Num/Page Volume 95, 102568
Publication Date 2025年6月6日

Affiliations:
[1] Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA
[2] Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA
[3] Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
[4] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, Tokyo, Japan
[5] Lurie Center for Autism, Massachusetts General Hospital, Lexington, MA, USA

More Bio2Q News

ANNOUNCEMENT
2025.11.29

Newsletter “Bio2Q Connect” (Vol. 2, Issue 11)

We are delighted to share with you Vol. 2, Issue 11 of WPI-Bio2Q Newsletter “Bio2Q Connect”. Major topics of this issue include: The 3...

ANNOUNCEMENT
2025.11.28

New Research Internship Student - Ms. Julia Tsanis-Horniblow  

Introducing a new Research Internship Student of Bio2Q We are delighted to welcome Ms. Julia Tsanis-Horniblow as a Research Internship Stud...

ANNOUNCEMENT
2025.11.28

Six WPI-Bio2Q Researchers Recognized as “Highly Cited Researchers 2025”

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) is proud to announce that six of our researchers were selected ...

RESEARCH
2025.11.21

[Publication]Monitoring ferroptosis in vivo: Iron-driven volatile oxidized lipid...

Researchers from Bio2Q and Keio University have developed a noninvasive method to detect ferroptosis by analyzing volatile oxidized lipids i...

ANNOUNCEMENT
2025.11.21

New Research Internship Student - Ms. Enya Mistry

Introducing a new Research Internship Student of Bio2Q We are delighted to welcome Ms. Enya Mistry as a Research Internship Student of Bio2...